03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Eduard Serra
IGTP researcher and co-lead author of the study
press citation on 1 topic since 22 Jun 2026 · last quoted 22 Jun 2026
02 Quoted on · 1 of 29 topics
Eduard Serra: key facts
- Kind of voice
- Academic
- Role
- IGTP researcher and co-lead author of the study
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 22 Jun 2026
04 The signal · where Eduard Serra sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Tarun DuaAcademicUnit Head of Brain Health at the World Health Organization and colead of the WHO Global Action Plan for Rare Diseases1
- 25=Conxi LázaroAcademicco-leader of the Hereditary Cancer group at IDIBELL and ICO and member of REMMA Bellvitge1
- 25=Eduard SerraAcademicIGTP researcher and co-lead author of the study1
- 25=Itziar UriarteAcademicfirst author of the work1
- 25=Meritxell CarrióAcademicco-lead author of the study1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Eduard Serra has said
- idibell.cat1
Where Eduard Serra has been quoted
- 01An innovative cell model allows progress in the research of a rare diseaseidibell.cat · 22 Jun 2026
Verbatim
“This work has allowed us to reproduce in the laboratory, for the first time and in a very precise way, the progression of tumours associated with neurofibromatosis type 1 from benign stages to malignant forms”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.